These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 308429)

  • 21. Class of immunoglobulin deposition and prognosis in lupus nephritis.
    Donadio JV; Conn DL; Holley KE; Ilstrup DM
    Mayo Clin Proc; 1978 Jun; 53(6):366-72. PubMed ID: 651380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of immunoglobulin G anti-glomerular basement membrane antibodies eluted from kidneys of patients with glomerulonephritis. II. IgG subtypes and in vitro complement fixation.
    McPhaul JJ; Dixon FJ
    J Immunol; 1971 Sep; 107(3):678-84. PubMed ID: 4999091
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antibodies against native (double-strand) deoxyribonucleic acid and complement fixing antibodies in generalized lupus erythematosus with affected kidneys].
    Dostál C; Hána I; Bardfeld R; Stejskal J; Matl I; Zvárová J
    Vnitr Lek; 1984 May; 30(5):417-25. PubMed ID: 6331681
    [No Abstract]   [Full Text] [Related]  

  • 24. [DNA-immune complex].
    Izui S
    Nihon Rinsho; 1975 Sep; 33(9):2768-75. PubMed ID: 1104923
    [No Abstract]   [Full Text] [Related]  

  • 25. Reassessment of the clinical significance of native DNA antibodies in systemic lupus erythematosus.
    Miniter MF; Stollar BD; Agnello V
    Arthritis Rheum; 1979 Sep; 22(9):959-68. PubMed ID: 314292
    [No Abstract]   [Full Text] [Related]  

  • 26. [Binding of complement by anti-native desoxyribonucleic acid antibodies in systemic lupus erythematosus].
    Youinou P; Le Goff P; Jouquan J; Cledes J; Pennec Y; Mottier D; Abgrall JF; Tandé D; Cam P; Le Menn G
    Presse Med; 1985 Apr; 14(16):875-8. PubMed ID: 3158921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody avidity for native DNA in lupus nephritis.
    Koyama A; Narita M; Tojo S
    Contrib Nephrol; 1975; 4():72-82. PubMed ID: 1235100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Crithidia luciliae kinetoplast immunofluorescence test in systemic lupus erythematosus.
    Slater NG; Cameron JS; Lessof MH
    Clin Exp Immunol; 1976 Sep; 25(3):480-6. PubMed ID: 786521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The significance of C3 and C4 complement levels in lupus nephritis.
    Levo Y; Pick AI
    Int Urol Nephrol; 1974; 6(3-4):233-8. PubMed ID: 4549215
    [No Abstract]   [Full Text] [Related]  

  • 30. High titer anti-basement membrane antibodies in a subset of patients with pediatric systemic lupus erythematosus.
    Orjuela A; Suwanichkul A; Canter D; Minard CG; Devaraj S; Hicks MJ; Muscal E; Wenderfer SE
    Am J Nephrol; 2015; 41(3):241-7. PubMed ID: 25926050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterogeneity of antinucleolar antibody and IgE antinuclear antibody in patients with systemic rheumatic diseases.
    Miyawaki S; Ritchie RF
    J Immunol; 1974 Oct; 113(4):1346-52. PubMed ID: 4606613
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunoreactivity to nuclear antigens in systemic lupus erythematosus with or without nephritis, and in other connective tissue diseases, with particular reference to the RNA-protein antigen.
    Mulli JC; Cruchaud A
    Int Arch Allergy Appl Immunol; 1977; 53(3):279-89. PubMed ID: 300712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological studies concerning the nephritis of systemic lupus erythematosus.
    Koffler D; Schur PH; Kunkel HG
    J Exp Med; 1967 Oct; 126(4):607-24. PubMed ID: 4168098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lupus nephritis: immunofluorescence study of 54 cases.
    Morel-Maroger L; Méry JP; Richet G
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1183-6. PubMed ID: 4610502
    [No Abstract]   [Full Text] [Related]  

  • 35. Detection of anti-DNA antibodies by electrosyneresis and complement fixation technique in the serum of systemic lupus erythematosus.
    Kusaba T; Kodama T; Hachimine K; Kisu T
    Fukuoka Igaku Zasshi; 1978 Jul; 69(7):319-25. PubMed ID: 308477
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunologic findings, thrombocytopenia and disease activity in lupus nephritis.
    Clark WF; Linton AL; Cordy PE; Keown PE; Lohmann RC; Lindsay RM
    Can Med Assoc J; 1978 Jun; 118(11):1391-5. PubMed ID: 350367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lupus nephritis: varying complement-fixing properties of immunoglobulin G antibodies to antigens of cell nuclei.
    Tojo T; Friou GJ
    Science; 1968 Aug; 161(3844):904-6. PubMed ID: 4174454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Complement binding anti-DNA antibodies: its clinical significance in systemic lupus erythematosus].
    Pigrau A; Martínez-Vázquez JM; Bacardí R; Ocanña I; Pahissa A
    Med Clin (Barc); 1984 Dec; 83(19):787-91. PubMed ID: 6335542
    [No Abstract]   [Full Text] [Related]  

  • 39. Complement-fixing activity of antinuclear antibodies induced by procaine amide treatment.
    Klajman A; Farkas R; Ben-Efraim S
    Isr J Med Sci; 1973 May; 9(5):627-30. PubMed ID: 4123966
    [No Abstract]   [Full Text] [Related]  

  • 40. Cold-insoluble complexes and complement levels in systemic lupus erythematosus.
    Stastny P; Ziff M
    N Engl J Med; 1969 Jun; 280(25):1376-81. PubMed ID: 4181609
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.